| Similar Articles |
|---|
 |
BusinessWeek
October 4, 2004
Gene G. Marcial |
TriPath Imaging: The Prognosis Is Good Another diagnostic outfit has caught the eye of investors. Its stock, at $10 in April, sild to $7 in August but has since crept up to $8.30.   |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
The Motley Fool
May 8, 2009
Brian Orelli |
Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector? |
BusinessWeek
June 6, 2005
Catherine Arnst |
Better Odds Against Breast Cancer New treatments for breast cancer are more effective, and easier to live with |
BusinessWeek
May 9, 2005
Catherine Arnst |
Genentech's Lessons For Big Pharma The biotech company focuses on science -- not marketing, acquisitions, or patents. |
The Motley Fool
February 27, 2004
Alyce Lomax |
Genentech's Hope For the past two days, Genentech has been an example of what many investors hinge their hopes and dollars on. Yesterday's FDA approval of the company's groundbreaking cancer drug, Avastin, was the reason positive sentiment remained infectious today. |
Fast Company
July 1, 2007 |
Going on the Gold Standard What it takes for your company to join the cancer fight. |
The Motley Fool
April 26, 2004
Alyce Lomax |
Genentech's Lucky Day Genentech and OSI Pharmaceuticals jump in today's trading session after favorable trial results for a cancer drug. |
American Family Physician
September 1, 2001
Jim Nuovo |
New Tests for Cervical Cancer Screening Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful advantages over the conventional Pap smear... |
American Family Physician
January 1, 2007
Anne D. Walling |
Mastectomy vs. Breast-Conserving Therapy for DCIS Breast-conserving therapy has become more common than mastectomies to treat breast cancer. A recent study compared the outcomes of the two treatment strategies. |
Health
October 10, 2008 |
Cervical Cancer FAQ Signs, symptoms, prevention, and treatments are some of the topics explained here. |
Wired
Thomas Goetz |
Why Early Detection Is the Best Way to Beat Cancer By getting regular blood tests, doctors may be able to diagnose cancer early, giving the patient a 90 percent chance of survival. |
Managed Care
March 2007
Martin Sipkoff |
Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails. |
American Family Physician
August 1, 2000
Lecia M. Apantaku |
Breast Cancer Diagnosis and Screening Statistics on breast cancer risk, symptoms and recommended tests. |
Bio-IT World
April 16, 2004 |
Portraits in Proteomics Advances in identifying protein biomarkers are spurring new hope in cancer diagnostics, expediting detection and easing testing. |
American Family Physician
December 15, 2002
Randhawa & Fink |
Screening for Breast Cancer A case study and question-and-answer group on screening for breast cancer, based on the recommendations of the current U.S. Preventive Services Task Force |
American Family Physician
February 15, 2005
Sunga et al. |
Care of Cancer Survivors Cancer survivors are at increased risk for recurrence of their original malignancy. Surveillance following curative cancer treatment generally includes interval history and physical examinations every six months for five years. |
Managed Care
March 2007
Lola Butcher |
Plans Put Greater Emphasis On Cancer Management Increasingly, health plans are rolling out services designed to help cancer patients and, before that, plan members at a high risk of cancer, to improve their health care and, in doing so, limit costs. |
BusinessWeek
January 30, 2006
Catherine Arnst |
Going Broke To Stay Alive Rising prices for cancer treatments are making patients - and doctors - balk. |
Managed Care
January 2005
Sharon Baker |
Breast Cancer Screening: Some Plans Do Better Than Others Some of the nation's best health plans are coming up with creative ways to encourage women to get mammograms. |
The Motley Fool
April 12, 2005
Brian Gorman |
Genentech's Cancer Quest The company's achievements in lung cancer further strengthen its reputation as a cancer fighter. Would-be investors are best served by waiting patiently. |
Nurse Practitioner
November 2010
Dreadin & Mancuso |
Diagnostic breast evaluation: When to refer and what the results really mean Diagnostic breast imaging is an important tool in evaluating abnormal physical examination findings and assessing incomplete screening mammographic results. |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Finding a Cure for Cancer: The Option Market's Favorite Ideas What cancer stocks are investors taking seriously?: Allos Therapeutics... China Medical Technologies... Delcath Systems... Myriad Genetics... ZIOPHARM... |
American Family Physician
March 15, 2001 |
Cancer Screening Guidelines Faced with the broad, and sometimes conflicting, range of recommendations for cancer screening, family physicians must determine the most reasonable and up-to-date method of screening... |
American Family Physician
February 1, 2001
Thomas J. Gates |
Screening for Cancer: Evaluating the Evidence This article reviews the kind of evidence required to justify screening tests for cancer, with the goal of guiding family physicians through current and future screening controversies... |
BusinessWeek
October 17, 2005
Catherine Arnst |
Breast-Cancer Screening: How to Choose Women have varying risk factors for breast cancer and face more test options. Here are some key considerations for making a suitable choice. |
The Motley Fool
February 25, 2008
Brian Lawler |
A Positive Surprise for Genentech Biopharma Genentech's lead drug gets a conditional OK to treat breast cancer. |
American Journal of Nursing
October 2010
Eileen Thomas |
Men's Awareness and Knowledge of Male Breast Cancer This article reports on the findings of a qualitative study that explored the awareness and knowledge of male breast cancer among English-speaking men. |
BusinessWeek
September 5, 2005
Michael Arndt |
Fine-Tuning the Attack on Breast Cancer Genentech's Herceptin, the first drug approved for a specific group, helps patients who are genetically susceptible to a virulent form of the disease. |
Pharmaceutical Executive
February 1, 2013
William Looney |
Pathways to Progress Cancer is increasingly understood as a collection of rare and mostly treatable conditions rather than the impregnable, monolith portrayed in popular culture. Industry experts review current and pending efforts to turn great science into good practice. |
BusinessWeek
July 17, 2006
Bruce Einhorn |
A Key New Ally In The Cancer War China and its Western trade partners are fighting together on at least one front: the war on cancer. |
AskMen.com
September 30, 2000
Joshua Levine |
Male Breast Cancer Breast cancer is traditionally thought of as a female-related problem. Men, however, are as susceptible to the disease as women are. In many ways, the disease appears similarly in both sexes... |
BusinessWeek
October 17, 2005
Catherine Arnst |
Nancy G. Brinker: Promise Keeper Nancy G. Brinker's Race for the Cure has been key to funding advances in breast cancer research. |
BusinessWeek
July 3, 2006
Catherine Arnst |
A Ton Of Prevention The pros and cons of two drugs that may halve your risk of breast cancer. |
BusinessWeek
August 26, 2010
Tom Randall |
Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer. |
American Family Physician
February 15, 2005 |
Health Care After Cancer Treatment An informative patient hand-out on follow-up cancer care. |
BusinessWeek
June 21, 2004
Catherine Arnst |
Cancer Superdrugs, Costly Side Effects New therapies are extending lives, but the prices could weigh down the nation. Oncologists, pharmaceutical companies, and the government will have to focus on the best way to lower prices for these drugs. |
Pharmaceutical Executive
February 1, 2013
William Looney |
In Cancer, Process Drives Progress Today's most important public health story is the advance in our understanding of the biology of cancer. |
Managed Care
August 2007
Martin Sipkoff |
Soaring Price of Cancer Drugs Leads Plans To New Approaches Insurers are trying different methods, from pay for performance to promoting preventive care, to hold down cost of chemotherapy drugs. |
The Motley Fool
May 28, 2009
Brian Orelli |
Make Money, Fight Disease: The ASCO Preview The big cancer meeting is upon us. |
Salon.com
June 20, 2000
Naomi Mendelsohn |
Choosing the knife Healthy women at high risk for breast cancer are choosing to have both breasts removed, even while doctors are advocating less invasive treatments for those who are already sick |
| Information Today |
ebrary Offers Free Breast Cancer Searchable Information Center ebrary has announced that it has collaborated with librarians from other organizations to create an open access database of breast cancer publications in honor of the National Breast Cancer Awareness Month. |
American Journal of Nursing
October 2010
Amy M. Collins |
'Men Get Breast Cancer, Too!' Theron Bell has made raising public awareness of male breast cancer his life's work. |
Wired
August 2003
Jennifer Kahn |
The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine. |
Chemistry World
January 21, 2011
Jennifer Newton |
Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea. |
Pharmaceutical Executive
July 3, 2007
Sarah Houlton |
Global Report: Five-Year Survivor: European Edition The UK government's attitude seems to be that oncology treatments are hugely expensive -- and that too much of the National Health Service budget is vanishing into the pockets of drug companies. Will cancer networks fill the gap? |
BusinessWeek
October 17, 2005 |
The Laughter Cure Monique Spencer couldn't find what she wanted in books about breast cancer. So she wrote her own - and made it funny. |
American Family Physician
May 15, 2005 |
Early Prostate Cancer: What You Should Know A patient hand-out on the disease, who is at risk, diagnosis and treatment options. |
American Family Physician
October 1, 2000 |
Genetic Testing for Breast Cancer Risk: What Does It Mean to Me? What causes breast cancer?... What genes can cause breast cancer to be inherited?... What clues in my family history might show I've inherited a risk of breast cancer?... Does everyone who has family members with breast cancer have these mutated genes?... What should I do?... |
Salon.com
October 12, 1999
Damien Cave |
Male mastectomy Not many men get breast cancer, but too few are aware of the risk. |
